| Calmodulin activation of Aurora-A kinase (AURKA) is required during ciliary disassembly and in mitosis OV Plotnikova, AS Nikonova, YV Loskutov, PY Kozyulina, EN Pugacheva, ... Molecular biology of the cell 23 (14), 2658-2670, 2012 | 176 | 2012 |
| LPA signaling is regulated through the primary cilium: a novel target in glioblastoma YV Loskutov, CL Griffin, KM Marinak, A Bobko, NV Margaryan, ... Oncogene 37 (11), 1457-1471, 2018 | 54 | 2018 |
| Changes in immunoreactivity of orexin-A-positive neurons after intravenous lipopolysaccharide injection. SV Perekrest, TV Abramova, NS Novikova, YV Loskutov, VJ Rogers, ... Medical Science Monitor: International Medical Journal of Experimental and …, 2008 | 45 | 2008 |
| NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer YV Loskutov, PY Kozyulina, VK Kozyreva, RJ Ice, BC Jones, TJ Roston, ... Oncogene 34 (28), 3662-3675, 2015 | 44 | 2015 |
| NEDD9 depletion leads to MMP14 inactivation by TIMP2 and prevents invasion and metastasis SL McLaughlin, RJ Ice, A Rajulapati, PY Kozyulina, RH Livengood, ... Molecular Cancer Research 12 (1), 69-81, 2014 | 38 | 2014 |
| Dual targeting of mesenchymal and amoeboid motility hinders metastatic behavior BC Jones, LC Kelley, YV Loskutov, KM Marinak, VK Kozyreva, ... Molecular Cancer Research 15 (6), 670-682, 2017 | 37 | 2017 |
| Combination of eribulin and Aurora A inhibitor MLN8237 prevents metastatic colonization and induces cytotoxic autophagy in breast cancer VK Kozyreva, AA Kiseleva, RJ Ice, BC Jones, YV Loskutov, F Matalkah, ... Molecular cancer therapeutics 15 (8), 1809-1822, 2016 | 34 | 2016 |
| Kruppel-like factor 4 signals through microRNA-206 to promote tumor initiation and cell survival CC Lin, SB Sharma, MK Farrugia, SL McLaughlin, RJ Ice, YV Loskutov, ... Oncogenesis 4 (6), e155-e155, 2015 | 31 | 2015 |
| Nuclear Aurora-A kinase-induced hypoxia signaling drives early dissemination and metastasis in breast cancer: implications for detection of metastatic tumors KM Whately, MA Voronkova, A Maskey, J Gandhi, J Loskutov, H Choi, ... Oncogene 40 (37), 5651-5664, 2021 | 17 | 2021 |
| Prometastatic NEDD9 regulates individual cell migration via caveolin-1–dependent trafficking of Integrins PY Kozyulina, YV Loskutov, VK Kozyreva, A Rajulapati, RJ Ice, BC Jones, ... Molecular Cancer Research 13 (3), 423-438, 2015 | 16 | 2015 |
| ADP-Ribosylation Factor-Like 2 (ARL2) regulates cilia stability and development of outer segments in rod photoreceptor neurons ZC Wright, Y Loskutov, D Murphy, P Stoilov, E Pugacheva, AFX Goldberg, ... Scientific Reports 8 (1), 16967, 2018 | 14 | 2018 |
| Immunoreactivity of orexin-containing business in the hypothalamus and the level of expression of the preproorexin gene in these cells after administration of lipopolysaccharide SV Perekrest, KZ Shainidze, YV Loskutov, TV Abramova, NS Novikova, ... Neuroscience and Behavioral Physiology 43, 256-260, 2013 | 7 | 2013 |
| Immunoreactivity of hypothalamic orexin neurons and expression level of preproorexin gene in them after lipopolysaccharide injection SV Perekrest, KZ Shainidze, L IuV, TV Abramova, NS Novikova, ... Rossiiskii Fiziologicheskii Zhurnal Imeni IM Sechenova 97 (6), 573-579, 2011 | 5 | 2011 |
| Photon and proton irradiation in patient-derived, three-dimensional soft tissue sarcoma models S Roohani, J Loskutov, J Heufelder, F Ehret, L Wedeken, M Regenbrecht, ... BMC cancer 23 (1), 577, 2023 | 4 | 2023 |
| A RAS-independent biomarker panel to reliably predict response to MEK inhibition in colorectal cancer U Pfohl, J Loskutov, S Bashir, R Kühn, P Herter, M Templin, S Mamlouk, ... Cancers 14 (13), 3252, 2022 | 3 | 2022 |
| Targeting primary cilia–associated signaling in glioblastoma: guided approach for drug development Y Loskutov, EN Pugacheva Oncoscience 6 (1-2), 289, 2019 | 2 | 2019 |
| Establishment of PD3D models of sarcomas: A promising preclinical tool for improvement of sarcoma treatment. M Regenbrecht, R Sauer, M Niethard, CRA Regenbrecht, J Loskutov Journal of Clinical Oncology 40 (16_suppl), e23538-e23538, 2022 | 1 | 2022 |
| Turning data into information: Using PD3D® models to guide colorectal cancer therapy by Optim.AITM U Pfohl, M Mohd Abdul Rashid, JJ Lim, J Loskutov, L Wedeken, ... Cancer Research 84 (6_Supplement), 891-891, 2024 | | 2024 |
| PD3D®models as jacks-of-all-trades for cancer research and therapy response prediction L Wedeken, S Forbrig, K Herrera-Glomm, J Loskutov, U Pfohl, I Piven, ... Cancer Research 84 (6_Supplement), 4235-4235, 2024 | | 2024 |
| Mix and match-A comprehensive pipeline for matched patient-derived PDX and PD3D® modelsfor cancer research and preclinical drug development J Loskutov, E Oswald, L Wedeken, CJ Reinhard, J Schueler, ... Cancer Research 84 (6_Supplement), 240-240, 2024 | | 2024 |
